|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1139894719 |
| 003 |
OCoLC |
| 005 |
20231120010436.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
200212s2020 enk o 101 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d OCLCF
|d UKMGB
|d UKAHL
|d EBLCP
|d N$T
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d K6U
|d OCL
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC009318
|2 bnb
|
| 016 |
7 |
|
|a 019682766
|2 Uk
|
| 019 |
|
|
|a 1139895476
|a 1140718698
|
| 020 |
|
|
|a 9780128224519
|q (electronic bk.)
|
| 020 |
|
|
|a 0128224517
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128196120
|
| 020 |
|
|
|z 0128196122
|
| 035 |
|
|
|a (OCoLC)1139894719
|z (OCoLC)1139895476
|z (OCoLC)1140718698
|
| 050 |
|
4 |
|a RC271.C5
|
| 082 |
0 |
4 |
|a 616.99407
|2 23
|
| 245 |
0 |
0 |
|a Prognostic and therapeutic applications of RKIP in cancer /
|c edited by Benjamin Bonavida and Stavroula Baritaki.
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 336 |
|
|
|a still image
|b sti
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 505 |
0 |
|
|a <P>1. RKIP: General Properties in Human MalignanciesInsight on the Role of RKIP in Cancer through Key Protein Partners and Cellular Protrusions <i>Francoise Schoentgen </i>2. Function of BACH1 as a key target of RKIP in Breast Cancer <i>Marsha Rich Rosner & Jiyoung Lee </i>3. Pleiotropic Activities of RKIP in Cancer: Role in Survival, EMT, Chemo-immuno-resistance, and Autophagy <i>Yuhao Wang & Benjamin Bonavida </i>4. Role of RKIP in the Tumor Response to Photo-oxidative Damage <i>Valentina Rapozzi & Luigi Emilio Xodo </i>5. A Review of RKIP Promotion of Tumour Progression, Metastasis and Poor Outcome in Multiple Solid Tumour Types <i>Sharon Glynn, Eoin Dervan, & Dibyangana Bhattacharyya </i>6. Tumor hypoxic stress, cellular plasticity and RKIP <i>Salem Chouaib, St�ephane Terry, St�ephanie Buart, & Ab�er�emane Abdou </i>7. RKIP in Uterine Tissues <i>Pasquapina Ciarmela </i>8. The Role of RAF Kinase Inhibitor Protein in Hematologic Malignancies <i>Armin Zebisch </i>9. RKIP Regulation and Crosstalks Regulation of RKIP Expression in Breast Cancer Cells by miRNA <i>Kam Yeung, Julius Castro, Hussain N. Odeh, Christopher Figy, Miranda L. Yeung, & Robert Trumbly </i>10. The Master Cellular Regulators "RKIP & GSK3�#x94;: Their Interactions and Repercussions on Cancer <i>Mira Bosso & Fahd Al-Mulla </i>11. Identification of Regulatory Crosstalks between RKIP and BCRA1 Tumor Suppressors in Healthy Tissues and Cancer (Breast and Ovarian): Therapeutic Implications <i>Martina Rama & Benjamin Bonavida </i>12. RKIP a Master of Regulatory Pathways: Perspectives <i>Khosrow Kashfi, Yongxin Zhou, & Gabrielle M. Corrente </i>13. Local and Systemic Endothelial Dysfunction in Cancer: RKIP-Mimetic, Therapy of Cancer and Endothelium-Safety <i>Marta Smeda, Marek Grosicki, & Stefan Chlopicki </i>14. Stochastic Modeling for Investigation of Regulation of Transcription of RKIP gene <i>Alexandre Ramos, Leonardo dos Reis Gama, Mauro C�esar Cafund�o Morais, & Poliana Cristina de Melo Martins </i>15. Anti-cancer effect of RKIP via modulating autophagy during metastasis <i>Deok Ryong Kim & Mahmoud Ahmed </i>16. RKIP and Inflammation The Role of Raf Kinase Inhibitory Protein in Inflammation <i>Steve Shenouda, Fahd Al-Mulla, Mira Bosso,& Rasheed Ahmad </i>17. Role of RKIP in inflammatory responses <i>Xiaojian Wang & Wenlong Lin </i>18. RKIP: Prognostic and Therapeutic Implications RKIP in Human Diseases and its Potential as a Prognostic Indicator and Therapeutic Target <i>Apostolos Zaravinos & Theodoulakis Christofi </i>19. Therapeutic Targeting of SNAIL, RKIP and YY1 in Tumor Metastasis and Drug Resistance <i>Nadire �Ozenver & Thomas Efferth </i>20. Implications of RKIP protein in cancer prognosis and therapy response: a literature update <i>Diana Cardoso-Carneiro, Ana Raquel-Cunha, Joana Pinheiro, Maria Gabriela-Freitas, Patr�icia Font�ao, Rui M. Reis, & Olga Martinho </i>21. Theranostic Role of RKIP in Cancer <i>Ganji Purnachandra Nagaraju, Begum Dariya, Gayathri Chalikonda, & Afroz Alam </i>22. Downregulation of the Raf Kinase Inhibitory Protein (RKIP) in Clear Cell Renal Cell Carcinoma Associates with Poor Prognosis <i>Damu Tang</i> <i>Anil Kapoor, Xiaozeng Lin, David Rodrig</p></i>
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
| 650 |
|
0 |
|a Cyclin-dependent kinases
|x Inhibitors.
|
| 650 |
|
0 |
|a Enzyme inhibitors.
|
| 650 |
|
2 |
|a Enzyme Inhibitors
|0 (DNLM)D004791
|
| 650 |
|
6 |
|a Cancer
|x Chimioth�erapie.
|0 (CaQQLa)201-0004691
|
| 650 |
|
6 |
|a Kinases d�ependantes des cyclines
|0 (CaQQLa)201-0333916
|x Inhibiteurs.
|0 (CaQQLa)201-0380642
|
| 650 |
|
6 |
|a Antienzymes.
|0 (CaQQLa)201-0014725
|
| 650 |
|
7 |
|a Cancer
|x Chemotherapy
|2 fast
|0 (OCoLC)fst00845327
|
| 650 |
|
7 |
|a Enzyme inhibitors
|2 fast
|0 (OCoLC)fst00913597
|
| 655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
| 655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
| 655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
| 655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
| 700 |
1 |
|
|a Bonavida, Benjamin.
|
| 700 |
1 |
|
|a Baritaki, Stavroula.
|
| 711 |
2 |
|
|a International Symposium on "Prognostic and Therapeutic Implications in Cancer"
|n (2nd :
|d 2019 :
|c �Erakleion, Greece)
|
| 776 |
0 |
8 |
|i Print version:
|z 0128196122
|z 9780128196120
|w (OCoLC)1111642057
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128196120
|z Texto completo
|
